Serum levels of Asprosin in patients diagnosed with coronary artery disease (CAD): a case-control study.
Nariman MoradiFatima Zahraa FouaniAkram VatannejadAbbas Bakhti AraniSoraya ShahrzadReza FadaeiPublished in: Lipids in health and disease (2021)
The present study findings suggested a possible relation of serum asprosin with the pathogenesis of CAD, in particular through insulin resistance and dyslipidemia.